A50V (p.Ala50Val) variant of MYPN (Myopalladin)

A50V (p.Ala50Val) in MYPN (Myopalladin) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes population frequency data and structural context.

A50V (p.Ala50Val) variant details